PETALING JAYA: The National Pharmaceutical Regulatory Agency (NPRA) has only recorded two serious reports involving adverse events following immunisation (AEFI) among children aged between five and 11 years old as of Feb 25.
NPRA director Dr Roshayati Mohamad Sani said these two cases, both aged 10 years old, involved a girl who had existing asthma and a boy with Bell's Palsy or facial paralysis.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
